Solace Nutrition NeoPhe LNAA Medical Food Tablets

This 550-count bottle contains clinically proven NeoPhe LNAA tablets designed for phenylketonuria (PKU) management. Each 685 mg tablet provides a specialized medical food formulation containing large neutral amino acids (LNAA) that work to block phenylalanine absorption at the gut level.

Advanced PKU Management Solution

NeoPhe tablets offer a scientifically formulated approach to PKU treatment, providing double protection from phenylalanine while supporting nutritional needs. The advanced coating technology ensures slow release of amino acids, maintaining stable phenylalanine levels throughout the day.

Clinical Benefits and Applications

• Suitable for all types of phenylketonuria (PKU) and hyperphenylalaninemia (HPA)
• Designed for adults, teenagers, and children eight years or older with PKU
• Effective for BH4 non-responders and patients with high blood Phe levels
• Supports non-compliant, untreated, or late-diagnosed PKU patients

Key Product Features

• Clinically proven formula with large neutral amino acids (LNAA)
• Double protection mechanism against phenylalanine absorption
• Supports up to 80% regular diet flexibility
• Enhanced with essential vitamins and minerals
• Odorless and flavorless tablets with advanced slow-release coating
• No sugar content and free from common allergens

Important Usage Information

NeoPhe is a medical food that should be used under medical supervision. The advanced tablet coating technology prevents high concentration of amino acids in the stomach while maintaining stable phenylalanine levels. Always consult with a healthcare professional for proper dosage and administration guidance.